300957 Stock Overview
Engages in the manufacture and sale of skincare and makeup products in China. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
Yunnan Botanee Bio-Technology Group Co.LTD Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥47.68 |
52 Week High | CN¥74.00 |
52 Week Low | CN¥39.30 |
Beta | 0.69 |
11 Month Change | -10.29% |
3 Month Change | 14.67% |
1 Year Change | -34.24% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -77.38% |
Recent News & Updates
Recent updates
Shareholder Returns
300957 | CN Personal Products | CN Market | |
---|---|---|---|
7D | -5.9% | -3.0% | -2.8% |
1Y | -34.2% | -15.8% | 2.0% |
Return vs Industry: 300957 underperformed the CN Personal Products industry which returned -14.9% over the past year.
Return vs Market: 300957 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
300957 volatility | |
---|---|
300957 Average Weekly Movement | 10.9% |
Personal Products Industry Average Movement | 7.3% |
Market Average Movement | 8.4% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300957's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300957's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 3,852 | Zhenyu Guo | www.botanee.com.cn |
Yunnan Botanee Bio-Technology Group Co LTD engages in the manufacture and sale of skincare and makeup products in China. The company offers facial creams, toners, face masks, serums, and lotions, as well as makeup products, such as sunscreens, powders, BB creams, and makeup removers.
Yunnan Botanee Bio-Technology Group Co.LTD Fundamentals Summary
300957 fundamental statistics | |
---|---|
Market cap | CN¥20.03b |
Earnings (TTM) | CN¥592.37m |
Revenue (TTM) | CN¥6.11b |
33.8x
P/E Ratio3.3x
P/S RatioIs 300957 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300957 income statement (TTM) | |
---|---|
Revenue | CN¥6.11b |
Cost of Revenue | CN¥1.71b |
Gross Profit | CN¥4.40b |
Other Expenses | CN¥3.81b |
Earnings | CN¥592.37m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.41 |
Gross Margin | 72.04% |
Net Profit Margin | 9.70% |
Debt/Equity Ratio | 9.4% |
How did 300957 perform over the long term?
See historical performance and comparison